AROMANDO ANDREW (Chief Business Officer) purchased 116.1% of their position (29.60K shares) of ONCOLYTICS BIOTECH INC on the open market
Open‑market purchase worth $25.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/13/2026ACC: 0001493152-26-006541
Officer· Chief Business Officer
Since Feb 2026
+29.60K
Net shares
Net buyer
$25.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
29.60K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+29.60K
Price / share
$0.86
Trade value
$25.42K
% of position
116.1%
2/11/2026
25.50K→55.10K
Total
Net shares
+29.60K
Net value
$25.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/11/2026 | P · Purchase | +29.60K | $0.86 | $25.42K | 116.1% | 25.50K | 55.10K |
| Total | +29.60K | $25.42K | ||||||
Derivative Transactions0
No derivative transactions reported